Function: Uncharacterized; no annotated biological role in current databases.
Sequence Features: Contains hydrophobic regions (e.g., VVGFGFALFIGSIY
) and charged residues (e.g., KRKKWWEIL
), suggesting potential membrane interaction or protein binding .
The protein is produced via recombinant expression in E. coli, leveraging bacterial systems for scalable production. Key steps include:
Cloning: ORF15 is inserted into a plasmid with a His-tag.
Expression: Induced in E. coli under optimized conditions.
Purification: Affinity chromatography using nickel or cobalt columns (His-tag mediated) .
Quality Control: SDS-PAGE confirms purity (>90%), and mass spectrometry validates sequence integrity .
The term ORF15 is shared across multiple organisms, including:
Key Differentiation: The Spiroplasma virus SpV1-C74 ORF15 is unrelated to human ORF15 orthologs and lacks homology to disease-associated proteins .
KEGG: vg:944353
Spiroplasma virus SpV1-C74 Uncharacterized protein ORF15 is a 72-amino acid viral protein (UniProt ID: Q88417) encoded by the ORF15 gene of Spiroplasma virus SpV1-C74. The full amino acid sequence is: MKIKILKFLKRKKWWEILVYILVVGFGFALFIGSIYDKWDKLIKWERYFILIYVSCKFVFLIWISLMYFIYN . This protein is classified as "uncharacterized" because its precise biological function remains to be fully elucidated through structural and functional studies. For recombinant expression, it is typically produced with an N-terminal His-tag to facilitate purification and is expressed in E. coli expression systems .
Analysis of the ORF15 amino acid sequence reveals several notable structural features:
Region | Amino Acid Position | Characteristics |
---|---|---|
N-terminal | 1-15 | Positively charged region (MKIKILKFLKRKKWW) suggesting potential nucleic acid interactions |
Middle region | 16-40 | Hydrophobic stretch (EILVYILVVGFGFALFIGSIYD) indicating possible membrane association |
C-terminal | 41-72 | Mixed hydrophobic/hydrophilic residues with potential functional domains |
For optimal expression and purification of recombinant ORF15 protein, researchers should follow this methodological approach:
Expression system: Use E. coli as the heterologous expression host with an N-terminal His-tag fusion construct .
Purification protocol:
Post-purification processing:
This methodology consistently yields high-purity recombinant protein suitable for downstream applications in research settings.
The stability of recombinant ORF15 protein is highly dependent on proper storage conditions. Based on empirical data, the following protocol is recommended:
Short-term storage: Store working aliquots at 4°C for up to one week to minimize freeze-thaw cycles .
Long-term storage:
Reconstitution guidelines:
These storage recommendations are designed to preserve protein integrity and functionality for extended periods, which is critical for experimental reproducibility.
Structural characterization of ORF15 requires a multi-faceted approach due to its small size (72 amino acids) and potential membrane association:
Technique | Methodology | Expected Outcomes |
---|---|---|
X-ray Crystallography | Optimize crystallization using various precipitants and detergents | High-resolution 3D structure revealing secondary structural elements |
NMR Spectroscopy | Express 15N/13C-labeled protein in minimal media | Solution structure and dynamics information |
Circular Dichroism | Measure far-UV spectra (190-260 nm) | Secondary structure composition (α-helix, β-sheet percentages) |
Molecular Dynamics | Simulate protein behavior in membrane environments | Membrane interaction mechanisms and conformational changes |
The comprehensive structural information obtained through these methods would provide critical insights into potential functional domains and interaction interfaces of ORF15 .
To investigate the biological function of the uncharacterized ORF15 protein, researchers should implement a systematic functional genomics strategy:
Comparative genomics analysis:
Align ORF15 sequences across different Spiroplasma virus strains
Identify conserved domains suggesting functional importance
Map sequence variations to potential phenotypic differences
Protein-protein interaction studies:
Perform pull-down assays using His-tagged ORF15 as bait
Identify host bacterial proteins that interact with ORF15
Validate interactions using complementary techniques (co-immunoprecipitation, FRET)
Genetic manipulation approaches:
Generate ORF15 knockout or mutant viruses if feasible
Assess effects on viral replication, assembly, and host interaction
Conduct complementation studies to confirm phenotypes
These methodological approaches provide complementary data to construct a comprehensive understanding of ORF15's role in viral biology .
Researchers working with recombinant ORF15 protein may encounter several technical challenges:
Challenge | Manifestation | Solution |
---|---|---|
Poor solubility | Protein found primarily in inclusion bodies | Lower induction temperature (16-25°C); use solubility-enhancing tags; consider denaturing purification with refolding |
Low expression yield | Minimal protein band on SDS-PAGE | Optimize codon usage for E. coli; test different host strains (BL21(DE3), Rosetta); vary induction conditions |
Protein degradation | Multiple lower molecular weight bands | Add protease inhibitors; reduce induction time; purify at 4°C |
Tag interference | Altered protein function | Compare N-terminal vs. C-terminal tagged versions; include tag removal options |
Systematic optimization of expression and purification parameters is essential to overcome these challenges and obtain high-quality protein for downstream applications .
Quality assessment of purified ORF15 protein should include multiple analytical techniques:
Purity assessment:
SDS-PAGE analysis (target: >90% purity)
Size exclusion chromatography to detect aggregation
Mass spectrometry to confirm molecular weight (expected: approximately 8-9 kDa plus tag)
Structural integrity validation:
Circular dichroism to confirm proper secondary structure formation
Thermal shift assays to assess protein stability
Limited proteolysis to assess compact folding
Functional validation:
Binding assays with potential interaction partners
Lipid interaction studies if membrane association is suspected
Activity assays based on bioinformatic function predictions
This multi-parameter approach ensures that the recombinant protein maintains native-like properties suitable for reliable experimental results .
Based on sequence analysis suggesting potential membrane association, researchers investigating ORF15-membrane interactions should consider this methodological framework:
In vitro membrane binding assays:
Prepare liposomes with compositions mimicking Spiroplasma membranes
Incubate purified ORF15 with liposomes and assess binding through co-sedimentation
Analyze binding specificity by varying lipid compositions
Biophysical characterization:
Conduct surface plasmon resonance (SPR) with immobilized lipid bilayers
Perform Förster resonance energy transfer (FRET) between labeled ORF15 and membrane probes
Use atomic force microscopy to visualize membrane associations
Structural studies in membrane mimetics:
Solve protein structure in detergent micelles or nanodiscs
Identify membrane-interacting residues through hydrogen-deuterium exchange
These complementary approaches would provide mechanistic insights into how ORF15 may interact with host cell membranes during viral infection .
When researchers encounter contradictory results in ORF15 functional studies, they should implement a systematic troubleshooting approach:
Standardize experimental conditions:
Use consistent protein preparation methods
Control buffer conditions, temperature, and incubation times
Document all experimental parameters meticulously
Employ orthogonal techniques:
Validate key findings using multiple independent methods
Compare results from in vitro and in vivo systems
Use both structural and functional approaches
Isolate variables systematically:
Test effect of tags and fusion partners
Evaluate concentration-dependent effects
Assess impacts of experimental buffers and additives
Collaborative validation:
Engage independent laboratories to replicate critical experiments
Use standardized protocols and reagents
Report both positive and negative results
This methodological approach helps identify sources of experimental variation and builds consensus around reproducible findings .